Iqbal SP, Kakepoto GN, Iqbal SP
Tirzepatide | Vitamin B6 (Pyridoxine) Injection Sterile, preservative-free injectable solution containing Tirzepatide and Vitamin B6 (Pyridoxine) for subcutaneous use
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
use a titration series with appropriate vehicle and pathway controls
Retrieved May 9, 2022, from Lexicomp (n.d.)
AOD-9604 Protocol Mistakes & Troubleshooting 01 Missed dose A missed point in a community research schedule should be recorded as a protocol deviation